Overview
Ranee Mehra is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland.
Dr. Mehra is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Tongue Cancer.
Dr. Mehra is board certified in American Board Of Internal Medicine - Medical Oncology, 2007. She is actively involved in clinical research, co-authoring 119 peer reviewed articles and participating in 16 clinical trials. Dr. Mehra is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
16 South Eutaw Street, Floor 4, Baltimore, MD 21201
22 South Greene Street, Floor 1, Baltimore, MD 21201
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
16 Clinical Trials
Stoler Outpatient Cancer Clinic
Maria Baer is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Baer is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Splenectomy. Dr. Baer is board certified in American Board Of Internal Medicine - Hematology, 1984 and American Board Of Internal Medicine - Internal Medicine, 1983. Dr. Baer is currently accepting new patients.
Stoler Outpatient Cancer Clinic
Aaron Rapoport is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Rapoport is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Multiple Myeloma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Rapoport is board certified in American Board Of Internal Medicine - Internal Medicine, 1989 and American Board Of Internal Medicine - Hematology, 1992. Dr. Rapoport is currently accepting new patients.
Sidney Kimmel Comprehensive Cancer Center
Dr. Ivana Gojo is a Hematologist/Oncologist in Baltimore. Her clinical focus is on diagnosis and management of patients with acute leukemias (AML, ALL) and other myeloid malignancies (MDS, MPNs, CML), with emphasis on the development of novel therapeutic approaches for these diseases. She is nationally and internationally recognized expert in clinical translation of novel therapeutics for acute leukemias and principal investigator on multiple multi-center investigator-initiated studies. Dr. Gojo joined the Johns Hopkins faculty in 2012 as the Co-Director of Leukemia Drug Development Program. She has served on the National Cancer Institute (NCI) Investigational Drug Steering Committee since 2014. Dr. Gojo received a Service Star Award from Johns Hopkins Medicine Service Excellence in 2018 for her exemplary care of leukemia patients. Dr. Gojo contributed to the clinical translational and drug development effort of multiple novel agents targeting pathogenic pathways in patients with acute leukemia. Her research efforts are now concentrated on the development and integration of novel immunotherapies into therapeutic armamentarium for patients with acute leukemia. She mentors basic and clinical research fellows and junior faculty on the development and design of novel clinical trials and mechanistic laboratory studies associated with these trials. She served as a leukemia team leader on the National Institute of Health (NIH)/NCI N01 grant (Phase II consortium) (2009-2011), and is co-principal investigator (PI) on the Experimental Therapeutics (ET)-Clinical Trial Network (CTN) UM1 grant supporting early clinical trials. Dr. Gojo has served on the National Comprehensive Cancer Network guideline panel for AML since 2019, Myeloid Growth Factor guideline panel since 2015 and previously served on the MPNs guideline panel (2016-2019). She has extensive experience in the regulatory aspects of drug development and served as the Chair (2015-2016) and Co-Chair (2014-2015) of the Cancer Research Review Committee at Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, and serves as a member of the SKCCC Biostatistics Core Advisory Committee and SKCCC Clinical Research Office Coordinating Center Oversight Committee. Dr. Gojo is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Gojo is board certified in American Board Of Internal Medicine. Dr. Gojo is currently accepting new patients.
Frequently Asked Questions about Dr. Ranee Mehra
How do I make an appointment with Dr. Ranee Mehra?
You can book an appointment with Dr. Ranee Mehra by calling their office at 410-328-6866. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Ranee Mehra a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ranee Mehra is classified as an Elite expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Ranee Mehra specialize in?
While Dr. Ranee Mehra is a Hematology Oncology, they have specific expertise in Head and Neck Squamous Cell Carcinoma (HNSCC), Non-Small Cell Lung Cancer (NSCLC), and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Ranee Mehra participate in research or clinical trials?
Yes. Dr. Ranee Mehra has published 119 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Dr. Ranee Mehra's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Ranee Mehra accept my insurance?
Dr. Ranee Mehra accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-328-6866 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Distinguished
- Lung CancerDr. Mehra isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Mehra isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Small Cell Lung Cancer (SCLC)Dr. Mehra isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Tongue CancerDr. Mehra isDistinguished. Learn about Tongue Cancer.
- Advanced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Mehra isAdvanced. Learn about Adenoid Cystic Carcinoma.
- ALK-Positive Non-Small Cell Lung Cancer
- EGFR Positive Lung CancerDr. Mehra isAdvanced. Learn about EGFR Positive Lung Cancer.
- Epithelial-Myoepithelial Carcinoma
- GliomaDr. Mehra isAdvanced. Learn about Glioma.
- Large-Cell Lung CarcinomaDr. Mehra isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Laryngeal CancerDr. Mehra isAdvanced. Learn about Laryngeal Cancer.
- Lung AdenocarcinomaDr. Mehra isAdvanced. Learn about Lung Adenocarcinoma.
- Nasopharyngeal CarcinomaDr. Mehra isAdvanced. Learn about Nasopharyngeal Carcinoma.
- Olfactory NeuroblastomaDr. Mehra isAdvanced. Learn about Olfactory Neuroblastoma.
- Oral Squamous Cell CarcinomaDr. Mehra isAdvanced. Learn about Oral Squamous Cell Carcinoma.
- Pleuropulmonary BlastomaDr. Mehra isAdvanced. Learn about Pleuropulmonary Blastoma.
- Polymorphous Low Grade Adenocarcinoma
- Salivary Gland TumorsDr. Mehra isAdvanced. Learn about Salivary Gland Tumors.
- Squamous Cell Lung CarcinomaDr. Mehra isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Throat CancerDr. Mehra isAdvanced. Learn about Throat Cancer.
- Experienced
- Anal CancerDr. Mehra isExperienced. Learn about Anal Cancer.
- Anaplastic Thyroid CancerDr. Mehra isExperienced. Learn about Anaplastic Thyroid Cancer.
- Aseptic and Alopecic Nodules of Scalp (AANS)
- Bone TumorDr. Mehra isExperienced. Learn about Bone Tumor.
- Eccrine PorocarcinomaDr. Mehra isExperienced. Learn about Eccrine Porocarcinoma.
- Ewing SarcomaDr. Mehra isExperienced. Learn about Ewing Sarcoma.
- Follicular Thyroid CancerDr. Mehra isExperienced. Learn about Follicular Thyroid Cancer.
- Lacrimal Gland TumorDr. Mehra isExperienced. Learn about Lacrimal Gland Tumor.
- Lung NodulesDr. Mehra isExperienced. Learn about Lung Nodules.
- Magnesium DeficiencyDr. Mehra isExperienced. Learn about Magnesium Deficiency.
- Medullary Thyroid CarcinomaDr. Mehra isExperienced. Learn about Medullary Thyroid Carcinoma.
- MelanomaDr. Mehra isExperienced. Learn about Melanoma.
- MesotheliomaDr. Mehra isExperienced. Learn about Mesothelioma.
- Metastatic Brain TumorDr. Mehra isExperienced. Learn about Metastatic Brain Tumor.
- Metastatic Pleural TumorDr. Mehra isExperienced. Learn about Metastatic Pleural Tumor.
- Papillary Thyroid CancerDr. Mehra isExperienced. Learn about Papillary Thyroid Cancer.
- PIK3CA-Related Overgrowth SpectrumDr. Mehra isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Posterior Fossa TumorDr. Mehra isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- RetinoblastomaDr. Mehra isExperienced. Learn about Retinoblastoma.
- Sinus CancerDr. Mehra isExperienced. Learn about Sinus Cancer.
- Squamous Cell Skin CarcinomaDr. Mehra isExperienced. Learn about Squamous Cell Skin Carcinoma.
- TeratocarcinosarcomaDr. Mehra isExperienced. Learn about Teratocarcinosarcoma.
- Thyroid CancerDr. Mehra isExperienced. Learn about Thyroid Cancer.
